WASHINGTON, DC – The prevalence of chronic kidney disease (CKD) is higher in the United States than in Europe, partly because the incidence of risk factors like diabetes and obesity is higher in America than in most European countries, according to a Kidney Week 2019 presentation.
In contrast, blood pressure levels are lower in the U.S. than in Europe, said Kitty J. Jager MD, PhD, a professor of medical informatics and kidney epidemiology at Amsterdam University Medical Center in The Netherlands, during a talk on “CKD in the United States and Europe: Juxtaposing the Epidemiology and Evolution.”
Announced this week, the NKF Patient Network “will create an interactive community of chronic kidney disease (CKD) patients that link patient-entered data on their health history, outcomes and preferences with clinical and laboratory data obtained from electronic health records. This unique combination of data collected will enable individualized educational resources, research, clinical care and health policy decisions to be centered on the patient.”
The ISN Global Kidney Health Atlas gathers “data to determine the world status of existing resources, structures and organizations available to patients with CKD and AKI”. The Atlas “is designed to document the degree to which the six principles of Universal Health Coverage (Health Finance, Health Policy, Service Delivery and Safety, Essential Medications and Health Products, Health Information and Statistics, and Health Workforce) are available in each county or region”.
In a joint press release in June 2018, the American Society of Nephrology (ASN), the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), and the International Society of Nephrology (ISN), publicized that the current number of people who suffer from kidney diseases worldwide has reached over 850 million and it's time to raise awareness for action to help alleviate the epidemic.
Outlined in a recent report from CNBC by Lori Ioannous (@Loriloannou1), chronic kidney disease is a “modern-day plague in the United States, driven in large part by the nation’s obesity epidemic”. 30 million Americans, or 1 in 9 adults, have chronic kidney disease, with diabetes and hypertension being major causes. “More than 510,000 kidney patients are now on dialysis, and over 100,000 are on the kidney transplant list”.
In a bold move up the ladder of electronic health record (EHR) interoperability, the Centers for Medicare and Medicaid Services (CMS) and the Office of National Coordinator for Health Information Technology (ONC) released two proposed rules February 11 designed to allow patients access to their own records and data – particularly via apps – and provide strong deterrents to those who would block data.
Today, June 22nd 2018, the US House of Representatives passed H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. H.R. 6 combines more than 50 bills approved individually by the House.
The bipartisan bill is designed to help overall efforts to combat the opioid crisis by advancing treatment and recovery initiatives, bolstering prevention efforts, and trying to counter deadly illicit synthetic drugs like fentanyl.